^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Anal Carcinoma |
| Drug: | cisplatin (DNA synthesis inhibitor) + 5-fluorouracil (Thymidylate synthase inhibitor) + capecitabine (Thymidylate synthase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
09/01/2021
Excerpt:
Cisplatin in combination with 5-FU/capecitabine, carboplatin or docetaxel-based combinations are alternatives in patients with ChT-naive advanced anal cancer [III, B].
